The patient presented on referral for short bowel syndrome, secretory diarrhea, and malabsorption.

The new treatments are for cancer, colitis, migraine, short bowel syndrome and Parkinson's disease.

We also discuss the management of short bowel syndrome.

Significant long-term morbidity, however, included short bowel syndrome.

Patients with short bowel syndrome lack sufficient functional intestine to sustain themselves with enteral intake alone.

However, a lower dosage proved effective in treating short bowel syndrome in 46 percent of the patients.

This operation cured bleeding peptic ulcer and also palliated the diarrhea, a main clinical manifestation of short bowel syndrome.

Methods: Thirteen patients with short bowel syndrome underwent anthropometric measurements and indirect calorimetry for the determination of resting energy expenditure.

We report a case of a male infant with concomitant short bowel syndrome and transient hypothyroidism treated with rectal L-T4.

Conclusions: Intestinal transplantation is a valid therapeutic option for children with definitive intestinal failure and not only for short bowel syndrome.

Conclusions: At its current price, teduglutide does not provide a cost-effective addition to transplantation in the treatment of pediatric short bowel syndrome.

An estimated 10,000 to 15,000 American adults have short bowel syndrome severe enough to require intravenous feeding.

In our report of a patient suffering from short bowel syndrome, vagotomy and pyloroplasty were performed to repair a sudden peptic hemorrhage.

Objective: The objective of the present study was to compare measured energy expenditure with predicted energy expenditure in patients with short bowel syndrome.

Conclusion: The energy expenditure of patients with short bowel syndrome can be estimated by use of the Harris-Benedict equation and patients' ideal weight.

Purpose of review: This article discusses the current state of the art in artificial intestine generation in the treatment of short bowel syndrome.